Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bending

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
STAR Protocols|February 16, 2022
Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse modelLozan Sheriff, David Bending
The Journal of Allergy and Clinical Immunology|April 11, 2017
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modelingDavid Bending, Masahiro Ono
Current Opinion in Immunology|February 10, 2023
Nr4a nuclear receptors: markers and modulators of antigen receptor signalingDavid Bending, Julie Zikherman
Frontiers in Immunology|October 19, 2018
Foxp3 Molecular Dynamics in Treg in Juvenile Idiopathic ArthritisAlastair Copland, David Bending
Nature Immunology|October 19, 2017
FoxP3 partners upDavid Bending, Masahiro Ono
Cell Reports. Medicine|March 31, 2023
T cell biomarkers come to the fore in cancer immunotherapyLozan Sheriff, Alastair Copland, David Bending
International Immunology|March 27, 2012
Inflammation and type one diabetesDavid Bending, Paola Zaccone, Anne Cooke
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2015
Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein ExpressionDavid Bending, Eirini Giannakopoulou, Hannah Lom, et al.
Essays in Biochemistry|June 30, 2023
T-cell response to checkpoint blockade immunotherapies: from fundamental mechanisms to treatment signaturesThomas A E Elliot, David A J Lecky, David Bending
STAR Protocols|February 3, 2021
Application of dual <i>Nr4a1</i>-GFP <i>Nr4a3</i>-Tocky reporter mice to study T cell receptor signaling by flow cytometryEmma K Jennings, David A J Lecky, Masahiro Ono, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
STAR Protocols|February 16, 2022
Flow cytometric analysis of CD4+ T cell reactivation following anti-PD1 immunotherapy in a transgenic mouse modelLozan Sheriff, David Bending
The Journal of Allergy and Clinical Immunology|April 11, 2017
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modelingDavid Bending, Masahiro Ono
Current Opinion in Immunology|February 10, 2023
Nr4a nuclear receptors: markers and modulators of antigen receptor signalingDavid Bending, Julie Zikherman
Frontiers in Immunology|October 19, 2018
Foxp3 Molecular Dynamics in Treg in Juvenile Idiopathic ArthritisAlastair Copland, David Bending
Nature Immunology|October 19, 2017
FoxP3 partners upDavid Bending, Masahiro Ono
Cell Reports. Medicine|March 31, 2023
T cell biomarkers come to the fore in cancer immunotherapyLozan Sheriff, Alastair Copland, David Bending
International Immunology|March 27, 2012
Inflammation and type one diabetesDavid Bending, Paola Zaccone, Anne Cooke
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2015
Synovial Regulatory T Cells Occupy a Discrete TCR Niche in Human Arthritis and Require Local Signals To Stabilize FOXP3 Protein ExpressionDavid Bending, Eirini Giannakopoulou, Hannah Lom, et al.
Essays in Biochemistry|June 30, 2023
T-cell response to checkpoint blockade immunotherapies: from fundamental mechanisms to treatment signaturesThomas A E Elliot, David A J Lecky, David Bending
STAR Protocols|February 3, 2021
Application of dual <i>Nr4a1</i>-GFP <i>Nr4a3</i>-Tocky reporter mice to study T cell receptor signaling by flow cytometryEmma K Jennings, David A J Lecky, Masahiro Ono, et al.
Pageof 4